Sale!

MARVELD2 Gene Deafness Autosomal Recessive Type 49 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MARVELD2 gene plays a crucial role in hearing processes, and mutations in this gene can lead to deafness autosomal recessive type 49 (DFNB49), a form of hereditary hearing loss. This condition is characterized by the absence or severe impairment of hearing from birth. Genetic testing for DFNB49 is essential for early diagnosis, which can significantly benefit from early interventions and management strategies for affected individuals.

DNA Labs UAE offers a specialized genetic test to detect mutations in the MARVELD2 gene associated with deafness autosomal recessive type 49. The test involves analyzing the individual’s DNA to identify any genetic alterations that could lead to this specific type of hearing loss. This precise genetic testing is crucial for families with a history of hearing loss, providing them with valuable information regarding the risk and inheritance patterns of this condition.

The cost of the MARVELD2 gene deafness autosomal recessive type 49 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify the genetic mutations responsible for this condition, offering families and individuals critical insights into managing and potentially mitigating the impacts of hereditary hearing loss.

Description

MARVELD2 Gene Deafness Autosomal Recessive Type 49 Genetic Test

Test Name: MARVELD2 Gene Deafness Autosomal Recessive Type 49 Genetic Test

Components: MARVELD2 gene analysis

Price: AED 4400.0

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN31

Test Details:

The MARVELD2 gene is associated with deafness, specifically autosomal recessive type 49 (DFNB49). Autosomal recessive means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the condition.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the identification of genetic variations that may be associated with certain conditions or diseases. In the case of MARVELD2 gene deafness, an NGS genetic test would analyze the MARVELD2 gene to determine if there are any mutations or variations present that could contribute to the development of autosomal recessive type 49 deafness.

The NGS genetic test would involve obtaining a sample of DNA, typically through a blood or saliva sample, and then sequencing the MARVELD2 gene to identify any potential mutations. The results of the test would indicate whether an individual has any mutations in the MARVELD2 gene that could lead to deafness.

It is important to note that genetic testing for deafness can help provide a diagnosis or risk assessment, but it may not be able to predict the severity or progression of the condition. Additionally, genetic testing may have limitations, such as not detecting all possible mutations or variations that could be associated with the condition. Therefore, it is recommended to consult with a genetic counselor or healthcare professional to fully understand the implications of genetic testing and its results.

Test Name	MARVELD2 Gene Deafness autosomal recessive type 49 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Ear Nose Throat Disorders
Doctor	ENT Doctor
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN31
Test Details	The MARVELD2 gene is associated with deafness, specifically autosomal recessive type 49 (DFNB49). Autosomal recessive means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the condition. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the identification of genetic variations that may be associated with certain conditions or diseases. In the case of MARVELD2 gene deafness, an NGS genetic test would analyze the MARVELD2 gene to determine if there are any mutations or variations present that could contribute to the development of autosomal recessive type 49 deafness. The NGS genetic test would involve obtaining a sample of DNA, typically through a blood or saliva sample, and then sequencing the MARVELD2 gene to identify any potential mutations. The results of the test would indicate whether an individual has any mutations in the MARVELD2 gene that could lead to deafness. It is important to note that genetic testing for deafness can help provide a diagnosis or risk assessment, but it may not be able to predict the severity or progression of the condition. Additionally, genetic testing may have limitations, such as not detecting all possible mutations or variations that could be associated with the condition. Therefore, it is recommended to consult with a genetic counselor or healthcare professional to fully understand the implications of genetic testing and its results.